Sign in to continue:

Sunday, July 26th, 2026

Alpha Teknova, Inc. Files Form 8-K Announcing Board and Officer Changes – 2026 Company Overview and Details

Alpha Teknova, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Alpha Teknova, Inc. (NASDAQ: TKNO) has released the results of its 2026 Annual Meeting of Stockholders, held on June 1, 2026. This report includes several key matters that are important for shareholders and may be of interest to investors monitoring the company’s strategic direction and governance.

Key Highlights from the Report

  • Date of Meeting: June 1, 2026
  • Location and Company Details: The company is headquartered at 2451 Bert Drive, Hollister, California, and is incorporated in Delaware.
  • Common Stock Outstanding: As of the record date, there were 53,636,790 shares of common stock outstanding. At the meeting, 47,821,520 shares, representing 89.20% of the total, were present or represented by proxy, indicating strong shareholder engagement.

Matters Voted Upon

  1. Election of Directors:

    • Shareholders were asked to elect two directors to serve as Class II directors until the 2029 Annual Meeting and until their successors are duly elected and qualified.
    • Nominees: J. Matthew Mackowski and Brett Robertson.
    • Voting Results:

      • J. Matthew Mackowski: 43,723,902 votes for, 3,061,015 votes withheld, and 1,036,603 broker non-votes.
      • Brett Robertson: 43,723,902 votes for, 3,061,015 votes withheld, and 1,036,603 broker non-votes.
    • Both nominees were re-elected to the Board of Directors, ensuring continuity in the company’s leadership.
  2. Other Proposals:

    • Shareholders considered two proposals, as outlined in the company’s definitive proxy statement filed with the SEC on April 21, 2026. However, this 8-K filing details only the director elections and does not specify the nature or outcome of the second proposal.

Emerging Growth Company Status

The company has indicated that it qualifies as an “Emerging Growth Company” under SEC definitions. This status allows Alpha Teknova, Inc. to take advantage of certain reduced regulatory requirements and may impact its financial reporting and disclosure obligations. However, the company has not elected to opt out of the extended transition period for complying with new or revised accounting standards.

Other Regulatory Disclosures

  • Trading Information: Alpha Teknova’s common stock is listed on the Nasdaq Stock Market under the ticker symbol “TKNO.”
  • SEC Filing Details: The company’s SEC file number is 001-40538, and the Employer Identification Number (EIN) is 94-3368109.

Important Information for Shareholders

  • The re-election of board members J. Matthew Mackowski and Brett Robertson ensures stability in the company’s strategic direction.
  • There were no director departures, nor were there changes in executive management or compensatory arrangements disclosed in this report.
  • No price-sensitive issues such as mergers, acquisitions, spin-offs, or material changes to the business were reported in this filing.
  • The high percentage of shares present or represented by proxy (89.2%) reflects strong shareholder engagement, which is generally viewed positively by the market.
  • The company’s status as an Emerging Growth Company means it may continue to benefit from certain cost savings and regulatory flexibility compared to mature public companies.

Conclusion

While the business update is routine and focused on annual governance matters, investors should note the company’s continued stability at the board level and its strong shareholder participation. There are no immediate, price-sensitive actions or significant strategic shifts disclosed in this filing.



Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review official filings and consult their financial advisors before making investment decisions.


View Alpha Teknova, Inc. Historical chart here



Jade Biosciences Appoints Andrew King as President of Research & Development – 8-K SEC Filing Update

Jade Biosciences, Inc. Announces Appointment of New Presiden...

Fiserv, Inc. Q1 2026 Financial Report: Revenue, Earnings, and SEC Filing Highlights

Fiserv, Inc. Q1 2026 Earnings and Financial Report: Key High...

Albany International Corp. Reports Q1 2026 Financial Results and Highlights Growth in Engineered Composites

Albany International Corp. Q1 2026 Financial Results: Compre...